213 related articles for article (PubMed ID: 7929847)
1. The expression and function of G-proteins in experimental intimal hyperplasia.
Davies MG; Ramkumar V; Gettys TW; Hagen PO
J Clin Invest; 1994 Oct; 94(4):1680-9. PubMed ID: 7929847
[TBL] [Abstract][Full Text] [Related]
2. The temporal sequence of G-protein expression in intimal hyperplasia.
Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
[TBL] [Abstract][Full Text] [Related]
3. External support modulates G protein expression and receptor coupling in experimental vein grafts.
Huynh TT; Iaccarino G; Davies MG; Safi HJ; Koch WJ; Hagen PO
Surgery; 1999 Aug; 126(2):127-34. PubMed ID: 10455874
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Davies MG; Huynh TT; Hagen PO
J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of alpha1-adrenergic receptors in experimental vein grafts.
Davies MG; Huynh TT; Hagen PO
J Surg Res; 1999 Jun; 84(1):40-5. PubMed ID: 10334887
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts.
Huynh TT; Iaccarino G; Davies MG; Svendsen E; Koch WJ; Hagen PO
Surgery; 1998 Aug; 124(2):177-86. PubMed ID: 9706136
[TBL] [Abstract][Full Text] [Related]
7. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
8. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
9. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
[TBL] [Abstract][Full Text] [Related]
11. G-protein expression and intimal hyperplasia after arterial injury: a role for Galpha(i) proteins.
Davies MG; Mason DP; Tran PK; Deou J; Hawkins S; Clowes AW
J Vasc Surg; 2001 Feb; 33(2):408-18. PubMed ID: 11174797
[TBL] [Abstract][Full Text] [Related]
12. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
13. Influence of perioperative storage solutions on long-term vein graft function and morphology.
Davies MG; Hagen PO
Ann Vasc Surg; 1994 Mar; 8(2):150-7. PubMed ID: 8198948
[TBL] [Abstract][Full Text] [Related]
14. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
15. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
[TBL] [Abstract][Full Text] [Related]
18. Modulation of tissue factor protein expression in experimental venous bypass grafts.
Channon KM; Fulton GJ; Davies MG; Peters KG; Ezekowitz MD; Hagen PO; Annex BH
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1313-9. PubMed ID: 9261261
[TBL] [Abstract][Full Text] [Related]
19. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
